Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)
Key facts
- Who runs it
- VA Connecticut Healthcare System
- Where
- West Haven, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 160 people, planned
- Started
- 8 Aug 2022
- Planned end
- 31 Oct 2026
- Type of study
- Interventional, 4 groups
- Treatments tested
- Donepezil + Cognitive remediation therapy (CRT)
- Donepezil + Placebo CRT
- Placebo medication + Cognitive remediation therapy (CRT)
- Placebo medication + Placebo CRT
- Record updated
- 23 June 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Males and females 18-80 years of age
- Fluency in English and a 6th grade or higher reading level
- Meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for a current alcohol use disorder (subjects should have a primary alcohol use disorder [AUD] diagnosis, but may have concurrent occasional use of other substances)
- Last alcohol use and at least one heavy drinking day within the past 30 days
- Willingness to attend follow-up assessments at 13 weeks
- Willingness to submit to Urine Toxicology screenings
Who cannot take part
- Current treatment with opioids or benzodiazepines, which may affect new learning
- Lifetime diagnosis of a psychotic disorder, not induced by drug use
- Medical illness that may significantly compromise cognition (e.g., Parkinson's, Alzheimer's, Huntington's chorea, moderate or greater TBI)
- An uncorrected sensory impairment (hearing or sight) that would seriously interfere with cognitive training
- Allergy to donepezil
- Unstable cardiovascular disease or unstable medical condition-clinically determined by a physician
- Involvement in a legal case that may lead to incarceration during the study period
- Residential plans that would interfere with participation
- Pre-morbid intelligence quotient (IQ) estimate below 70
- Unstable housing or lack of commitment to staying within a geographic area that would make follow-up unlikely
- Unwillingness to provide contact information of someone who can help study staff contact the subjects in the event that study staff are unable to maintain contact directly
- Imminent suicidal or homicidal risk
- Pregnant or nursing women, positive pregnancy test, or inadequate birth control methods in women of childbearing potential
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- VA Connecticut Healthcare SystemWest Haven, United StatesContact: Gihyun Yoon, MDTaking people
About the trial
What the trial wants to find out
The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.
The 4 groups in the trial
- Donepezil + Cognitive remediation therapy (CRT)Treatment being tested
Subjects in this arm will receive (1) donepezil and (2) cognitive remediation therapy (CRT). Subjects will take 5 mg/day of oral donepezil in the evening for the first 4 weeks, then 10 mg/day of oral donepezil in the evening until week 13.
- Donepezil + Placebo CRTTreatment being tested
Subjects in this arm will receive (1) donepezil and (2) placebo CRT. Subjects will take 5 mg/day of oral donepezil in the evening for the first 4 weeks, then 10 mg/day of oral donepezil in the evening until week 13.
- Placebo medication + Cognitive remediation therapy (CRT)Treatment being tested
Subjects in this arm will receive (1) placebo medication and (2) cognitive remediation therapy (CRT). Subjects will take placebo oral medication in the evening for the first 4 weeks, then placebo oral medication in the evening until week 13.
- Placebo medication + Placebo CRTTreatment being tested
Subjects in this arm will receive (1) placebo medication and (2) placebo CRT. Subjects will take placebo oral medication in the evening for the first 4 weeks, then placebo oral medication in the evening until week 13.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder
- Fit questions
- Built from NCT05042102, who can take part
- Publications
- Record updated
- 23 June 2026